Healthed Webcast

Practical Guide to Using GLP-1RAs for Type 2 Diabetes in Primary Care – Expert Panel – Facilitator A/Prof Ralph Audehm, Panelists Prof Richard O'Brien & Prof Richard MacIsaac

GLP-1 receptors agonists are an increasingly popular treatment option for patients with type 2 diabetes. But what does the evidence say?

Managing type 2 diabetes has become a complicated challenge as more and more therapeutic options become available. The GLP-1 receptor agonists are one of the more recent additions, and the evidence-base for their usefulness continues to grow.

But exactly what does the research say in terms of effectiveness, safety and long-term benefits, who do they work best for, who shouldn't take them, and when and where do they fit in to the algorithm for treating this progressive disease?

In this panel discussion, moderated by Associate Professor Ralph Audehm, Australian experts will address these very questions and provide some practical and evidence-based recommendations on how the patient presenting with type 2 diabetes in 2023 can be best managed to ensure their optimal future health.

COVID Update – Prof Adrian Esterman

As every practising GP in Australia will know, the COVID epidemic is far from over, despite what the WHO might tell us.

And while we no longer have lockdowns, QR check-ins or mandatory testing, the virus still represents a significant burden on our community, on primary care in particular. Even though governments seem reluctant to provide us with accurate data with which to get a true picture of the current status of the pandemic, GPs still need to be up to date on the latest variants, the morbidity associated with these variants, as well as new vaccines, treatments and therapies.

Don't miss the opportunity to update your COVID knowledge and stay ahead of the curve.

Optimising Dual Therapy in Asthma: When, Why and How – Dr David Freiberg

Changes in asthma guidelines and increases in treatment options available can sometimes make the management of this common condition a challenge.

The fundamental pathophysiology that underpins asthma is now recognised to exist even in the absence of symptoms, and not addressing this can increase the risk of exacerbations and make the persistence of symptoms much more likely. In this presentation, Dr David Freiberg will translate how the latest evidence-based recommendations can and should be applied in the clinical setting and how best to achieve optimal asthma symptom control, safely and effectively in the real-world setting.